Candida auris: no other infected patient at Pierre-Boucher Hospital

After the discovery of two patients infected with the fungus candida auris at the Pierre-Boucher Hospital in Longueuil, the CISSS de la Montérégie-Est confirmed to us that the other patients who were “under investigation” all received negative screening test results.

The opening of a national crisis unit following the discovery of this fungus at the Longueuil hospital center, revealed Thursday by Radio-Canada, has created concern among both patients and hospital staff. , most of whom were unaware of the presence of candida auris in their establishment.

The mushroom candida auris attacks hospitalized patients, primarily those with weakened immune systems and those undergoing surgery or intravenous therapy. An infected person has a 30 to 60% chance of dying.

In a press release published on Friday, the CIUSSS de la Montérégie-Centre assured that hatching of candida auris is well circumscribed in the hospital and the required infection prevention and control measures are applied.

The hospital remains a safe place of care for employees and clients. The population should not hesitate to go there if their state of health requires it or if they have to deal with it. »

A quote from Excerpt from the press release from the Montérégie-Centre Integrated Health and Social Services Center

All hospital activities continue; appointments are maintained and people scheduled for surgery can have surgery as scheduledcontinues the management of the CIUSSS.

As for people who have recently visited Hôpital Pierre-Boucher, Dr. Julie Loslier, public health director for Montérégie, wishes to reassure them and explains that only people who were present on the unit where the vs. auris has been found have been or will be contacted by our team.

The CIUSSS recalls that the transmission of the candida auris is done by touching contaminated surfaces or by direct contact between two people.

Hand hygiene remains the best protection.

With information from Thomas Gerbet

Follow by Email
Telegram
WhatsApp
FbMessenger